West Pharmaceutical Services, Inc

Medical Supplies
WST
$ 261 2
Share price
$ 19 bn
Market Cap
$ 19 bn
Enterprise Value

Carbon footprint

6.9 Ton
GHG emissions per $ 1 mln investment
0.18x the weighted average for S&P 500
FY2021
How is this calculated?
+6.1%
YOY change in GHG emissions
Stronger than the +5% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-1.1%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2022
How is this calculated?

West Pharmaceutical Services, Inc aims to reduce Scope 1 + 2 by 10% by 2023 from a base year 2018


This target has not been verified as science based according to SBTi
West Pharmaceutical Services, Inc's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

West Pharmaceutical Services, Inc's GHG emissions (market-based) (Kt of CO2e)
West Pharmaceutical Services, Inc's Carbon intensity (Tons per 1 USDm)

West Pharmaceutical Services, Inc's carbon footprint

West Pharmaceutical Services, Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 128 Kt (+7.4/+6.1% y-o-y). At the sime time, carbon intensity was down at 45 t (-11 /-19.5% y-o-y).

No public disclosure of Scope 3 emissions has been found for West Pharmaceutical Services, Inc at the moment.

The company is committed to reducing Scope 1 + 2 by 10% by 2023 from a base year 2018, which translates into the estimated reduction of -1.4 Kt per annum over the period of FY2022 - FY2023. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...